Impaired Endogen Fibrinolysis in Patients with Chronic Ischemic Heart Disease

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10252

Title:	Impaired Endogen Fibrinolysis in Patients with Chronic Ischemic Heart Disease
Authors:	Nurillaeva Nargiza Mukhtarkhanovna, Zokirova Muborakkhon Bobir qizi
Keywords:	Ischemic heart disease, hypercoagulation, Thrombin-activatable fibrinolysis inhibitor (TAFI), risk factors.
Issue Date:	2023
Publisher:	Journal of Survey in Fisheries Sciences
Series/Report no.:	10(2S) 2329-2334;
Abstract:	Cardiovascular disease is one of the main causes of mortality all of the world. Hypercoagulability is one of the pathogenetic mechanisms for the development of coronary heart disease. In our study, the main goal was to evaluate new markers of hypercoagulability and to establish the relationship between risk factors for coronary heart disease. Our results showed that The TAFI level in patients was authentically increased by 2.3 more time in patients compared to healthy individuals. At the same time, we found strong correlation between TAFI and the main risk factors of ischemic heart disease such as ADS, AH, obesity.
URI:	http://repository.tma.uz/xmlui/handle/1/10252
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
3_F_D_A_Нуриллаева_Н_М_,_Зокирова_М_Б_Скопус_ТАФИ_2.pdf	Impaired Endogen Fibrinolysis in Patients with Chronic Ischemic Heart Disease	213.14 kB	Adobe PDF	View/Open

DSpace JSPUI